Innoviva (INVA) Other Operating Expenses (2013 - 2025)

Innoviva has reported Other Operating Expenses for 7 years, with the latest figure at $4.3 million in Q3 2025.

• For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (changed N/A YoY), and the FY2022 full-year result was -$60.6 million, up 13.67% from the prior year.
• Other Operating Expenses for Q3 2025 stood at $4.3 million, up from -$51.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $62.1 million in Q2 2022, with the low at -$258.7 million in Q3 2022.
• Historically, Other Operating Expenses has averaged -$25.0 million across 4 years, with a median of $3.6 million in 2023.
• Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 803.79% — and 2023, when it surged 80.16%.
• Innoviva's Other Operating Expenses stood at -$28.6 million in 2021, then plunged by 803.79% to -$258.7 million in 2022, then surged by 80.16% to -$51.3 million in 2023, then surged by 108.32% to $4.3 million in 2025.
• The last three Other Operating Expenses figures came in at $4.3 million (Q3 2025), -$51.3 million (Q3 2023), and $36.7 million (Q2 2023), per Business Quant data.